BioAtla, Inc. BCAB
1.48
(0.04)
(2.63%)
as of 25 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow BCAB
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
2.93 | 2.52 | — | — | 1,149.85 | 668.31 | 953.36 | 953.36 | — |
P/FCF ratio |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(4.22) | (1.71) | — | — | (32.38) | (20.47) | (162.22) | (162.22) | — |
P/B ratio |
0.00 | 2.01 | — | — | 3.22 | 1.37 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 2.01 | — | — | 3.22 | 1.37 | 0.00 | 0.00 | — |
EV/Sales |
2.56 | (1.53) | — | — | 743.74 | 136.33 | 973.27 | 973.27 | — |
EV/EBITDA |
0.00 | 0.24 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.60) | 0.24 | — | — | (7.05) | (1.61) | (80.09) | (80.09) | — |
EV/FCF |
(0.60) | 0.24 | — | — | (6.95) | (1.58) | (76.04) | (76.04) | — |
Quick Ratio |
0.32 | 3.37 | 3.93 | 9.32 | 12.36 | 7.40 | 0.14 | 1.18 | — |
Current Ratio |
0.37 | 3.52 | 4.11 | 9.53 | 12.48 | 7.46 | 0.17 | 1.38 | — |
Net Debt/EBITDA |
0.12 | 0.67 | 0.87 | 1.98 | 2.52 | 8.18 | (0.53) | (0.15) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.76% | 2.11% | 0.28% | 194.09% | 90.16% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | (0.32) | (0.53) | — |
Asset Turnover |
0.06 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 1.28 | — |
Operating CF/Net income |
0.81 | 1.03 | 0.84 | 0.85 | 0.65 | 1.01 | 0.34 | 1.25 | — |
Capex/Depreciation |
0.00 | 0.00 | (0.08) | (0.22) | (0.69) | (0.59) | (1.75) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 543.76% | (164.30%) | (98.37%) | (54.44%) | (45.34%) | (112.27%) | 21.77% | 21.41% | — | |
| (179.95%) | (81.10%) | (71.49%) | (44.35%) | (38.21%) | (28.20%) | (221.24%) | (338.57%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
432.28% | (186.72%) | (137.69%) | (53.23%) | (41.27%) | (16.87%) | 163.84% | (383.50%) | — |
Average Days of Receivables |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
2,178.65% | 573.59% | 0.00% | 0.00% | 23,309.60% | 4,646.39% | 498.44% | 240.06% | — |
Selling, General and Administrative Expense of Revenue |
886.60% | 198.62% | 0.00% | 0.00% | 15,366.40% | 2,469.70% | 145.17% | 118.15% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
271.70% | 81.10% | 0.00% | 0.00% | 10,046.80% | 704.43% | 0.00% | 0.00% | — |
Graham Net Nets |
(1.26) | 0.46 | — | — | 0.30 | 0.72 | 0.02 | 0.02 | — |
Graham Number |
186.94 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(177.82%) | (243.65%) | — | — | (14.11%) | (12.52%) | (0.48%) | (0.48%) | — |
Free Cash Flow Yield |
(144.55%) | (250.92%) | — | — | (9.31%) | (12.88%) | (1.34%) | (1.34%) | — |
Revenue per Share |
1.70 | 11.32 | 0.00 | 0.00 | 0.36 | 2.54 | 4.76 | 0.32 | — |
Operating CF per Share |
(40.97) | (74.05) | (108.85) | (116.15) | (90.01) | (215.50) | (8.83) | (1.05) | — |
Capex per Share |
0.00 | 0.00 | (0.10) | (0.34) | (1.34) | (3.50) | (1.38) | 0.00 | — |
Free Cash Flow per Share |
(40.97) | (74.05) | (108.95) | (116.49) | (91.35) | (219.00) | (10.21) | (1.05) | — |
Cash per Share |
6.05 | 50.48 | 116.65 | 276.82 | 354.43 | 1,415.21 | 3.39 | 0.32 | — |
Shareholders Equity per Share |
(30.76) | 14.68 | 73.96 | 231.65 | 305.01 | 1,245.40 | (51.29) | (0.85) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(30.76) | 14.68 | 73.96 | 231.65 | 305.01 | 1,245.40 | (51.29) | (0.85) | — |
Free Cash Flow |
(48.20) | (71.94) | (104.11) | (90.68) | (63.14) | (36.92) | (11.15) | (35.32) | — |
Working Capital |
(13.91) | 36.69 | 88.06 | 197.30 | 227.48 | 208.42 | (22.21) | 3.47 | — |
Capital Expenditures |
— | — | (0.10) | (0.26) | (0.92) | (0.59) | (1.51) | (0.99) | — |
Net Current Asset Value |
(42.00) | 13.08 | 67.42 | 175.03 | 203.69 | 205.72 | (60.84) | (32.42) | — |
EV/EBIT |
0.00 | 0.24 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 3.70 | 1.38 | 0.29 | 0.00 | — |
Net Profit Margin |
(2,980.35%) | (634.33%) | 0.00% | 0.00% | (38,160.80%) | (8,357.34%) | (552.52%) | (265.02%) | — |
Price to Operating Income |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
3.11 | 1.36 | 0.76 | 0.44 | 0.36 | 0.25 | 0.18 | 0.20 | — |
Cash ROIC |
166.23% | (114.69%) | (57.99%) | (23.30%) | (14.29%) | (9.00%) | 41.89% | 1,506.34% | — |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Average Payables |
15.03 | 20.21 | 24.17 | 20.02 | 15.25 | 12.02 | 6.97 | 3.55 | — |
Average Assets |
33.13 | 86.04 | 172.70 | 240.08 | 249.68 | 127.14 | 12.99 | 8.32 | — |
Average Common Equity |
(10.96) | 42.47 | 125.51 | 195.58 | 210.40 | 31.93 | (131.96) | (131.56) | — |
Columns are period end dates